ACTA1 and Hepatic fibrosis: For example, in an acute liver injury and early chronic liver fibrosis model, mice treated with a CXCR4 antagonist, AMD3100, expressed higher hepatic α-SMA and showed increased hepatic collagen content and fibrosis over untreated controls.